Cite
[Why multi-national clinical trials now?--Industry perspective].
MLA
Miki, Satoshi. “[Why Multi-National Clinical Trials Now?--Industry Perspective].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 34, no. 2, Feb. 2007, pp. 293–96. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17301547&authtype=sso&custid=ns315887.
APA
Miki, S. (2007). [Why multi-national clinical trials now?--Industry perspective]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 34(2), 293–296.
Chicago
Miki, Satoshi. 2007. “[Why Multi-National Clinical Trials Now?--Industry Perspective].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 34 (2): 293–96. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17301547&authtype=sso&custid=ns315887.